BRIEF-J&J says U.S. FDA expands indication of Invokamet

* U.S. FDA expands indication of Invokamet to include

first-line treatment of adults with type 2 diabetes

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more